Want to see TSE:BCT full AI Analyst Report?

BriaCell Therapeutics (BCT) Financial Statements

109 Followers

BriaCell Therapeutics Financial Overview

BriaCell Therapeutics's market cap is currently C$46.46M. The company's EPS TTM is C$-12.2; its P/E ratio is -0.31; BriaCell Therapeutics is scheduled to report earnings on June 9, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jul 25	Jul 24	Jul 23	Jul 22	Jul 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -107.93K	$ 0.00	$ 0.00	$ 0.00	$ -15.55K
Operating Income	$ -27.54M	$ -33.33M	$ -23.27M	$ -15.29M	$ -7.11M
EBITDA	$ -27.43M	$ -4.85M	$ -23.26M	$ -26.82M	$ -7.10M
Net Income	$ -26.63M	$ -4.79M	$ -20.30M	$ -26.84M	$ -13.82M
Balance Sheet
Cash & Short-Term Investments	$ 17.93M	$ 862.09K	$ 21.25M	$ 41.04M	$ 57.27M
Total Assets	$ 21.72M	$ 5.87M	$ 27.16M	$ 42.58M	$ 58.04M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 25.99K
Net Debt	$ -10.53M	$ -862.09K	$ -21.25M	$ -41.04M	$ -57.24M
Total Liabilities	$ 4.33M	$ 8.56M	$ 30.94M	$ 32.25M	$ 30.37M
Stockholders' Equity	$ 17.94M	$ -2.38M	$ -3.78M	$ 10.33M	$ 27.67M
Cash Flow
Free Cash Flow	$ -28.51M	$ -24.58M	$ -23.74M	$ -12.48M	$ -7.75M
Operating Cash Flow	$ -28.51M	$ -24.13M	$ -23.74M	$ -12.48M	$ -7.75M
Investing Cash Flow	$ -7.74M	$ -681.80K	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 46.00M	$ 4.42M	$ 3.95M	$ -3.74M	$ 65.00M

BriaCell Therapeutics Earnings and Revenue History

Income Statement >

BriaCell Therapeutics Debt to Assets

Balance Sheet >

BriaCell Therapeutics Cash Flow

Cash Flow >

BriaCell Therapeutics Forecast EPS vs Actual EPS

Earnings >